- Home
- VEL vs INMD Comparison
VEL vs INMD Comparison
Compare VEL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VEL | INMD |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 765.5M | 842.0M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VEL | INMD |
|---|---|---|
| Price | $18.46 | $14.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $22.00 | $17.33 |
| AVG Volume (30 Days) | 82.3K | ★ 741.0K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.98 | N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.01 | $1.74 |
| Revenue Next Year | $19.02 | $3.26 |
| P/E Ratio | $31.60 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.19 | $12.72 |
| 52 Week High | $21.40 | $16.74 |
Technical Indicators
Market Signals| Indicator | VEL | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 63.02 | 64.01 |
| Support Level | $17.82 | $14.58 |
| Resistance Level | $18.82 | $14.71 |
| Average True Range (ATR) | 0.44 | 0.25 |
| MACD | 0.13 | 0.16 |
| Stochastic Oscillator | 100.00 | 70.96 |
Price Performance
Historical ComparisonAbout VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.